Project Grant R01HD118111
- Federal Grant Award Summary The University of California, San Diego received a $151,040 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective January 25, 2026 through July 31, 2027. This research project investigates the effects of rare damaging mutations in Transforming Growth Factor-Beta (TGFB) latent complex proteins, specifically Fibronectin 1 (FN1) and...
- Federal Grant Award Summary The University of California, San Diego received a $452,000 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded August 1, 2025, with completion by July 31, 2027. This research project aims to identify a cellular immune signature unique to clinically-significant villitis of unknown etiology (VUE), a chronic inflammatory placental lesion...
- Federal Grant Award Summary Yale University received a $1,280,711 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective August 1, 2025 through April 30, 2030. This research initiative investigates the role of decidual extracellular vesicles (EVs) in mediating placental insufficiency, a pathological condition underlying obstetrical diseases including fetal growth...
- Federal Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded $429,000 in Project Grant funding to the University of Colorado-Denver for research conducted under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award was obligated on August 6, 2025, with a project completion date of July 31, 2027. This R21 mechanism grant supports research utilizing induced pluripotent stem cell (iPSC)...
- This Project Grant award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development provides $769,916 to Emergent Biotechnologies LLC for research into a novel therapy for preeclampsia. The funding supports Phase 1 of developing and characterizing a handle region peptide as an innovative treatment for preeclampsia under the Child Health and Human Development Extramural Research program (CFDA 93.865). Phase 1 work will...
- Federal Grant Award Summary The National Institute of Child Health and Human Development awarded $163,145 to the University of Colorado-Denver on August 7, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support a five-year research initiative (completion date: July 31, 2030). This K08 career development award funds a comprehensive research and training project investigating the role of trophoblast microRNAs (miRNAs) in fetal growth restriction...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $688,009 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective May 15, 2026, with completion targeted for February 28, 2031. This research project investigates trophoblast differentiation and placental aging mechanisms to improve pregnancy outcomes and...
- Federal Grant Award Summary Oregon Health & Science University received a $429,000 Project Grant from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded on August 11, 2025, with a completion date of July 31, 2027. This project, titled "Placental Cell- and Size-Specific Extracellular Vesicle RNA Cargo Analysis Throughout Human Gestation," develops and validates a novel multiplex...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a $462,538 Project Grant to Magee-Womens Research Institute and Foundation under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period of June 1, 2026 through May 31, 2028. The award funds research investigating CHD7-dependent regulation of migration and morphogenesis in the context of CHARGE syndrome, a congenital developmental disorder...
Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded $600,016 to the University of California, San Diego under the Child Health and Human Development Extramural Research program (CFDA 93.865) on June 1, 2026, for a project titled "Extracellular Vesicles as Mediators of Kidney Damage in Preeclampsia." The research will be conducted through February 28, 2031. This project grant supports investigator-initiated biomedical research designed to advance understanding of pregnancy-related complications and improve maternal health outcomes. The project will deliver fundamental research on the mechanisms of kidney injury associated with preeclampsia, a hypertensive disorder affecting 2-10% of pregnant women and accounting for 16% of maternal deaths in the United States. The research team will utilize a novel 3D microfluidic human proximal tubule kidney-on-a-chip model to investigate how placental and maternal serum extracellular vesicles (EVs) interact with renal cells and cause kidney damage in severe preeclampsia. The study will examine EVs from both early and late-onset preeclampsia cases compared to normal pregnancy, employing both the microfluidic kidney model and mouse model systems to elucidate previously unexplored mechanisms of pregnancy-related acute kidney injury.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $600.0k | 5/27/26 |